McCain Tracey L
SEC insider (Form 3/4/5 filer). CIK 0001683600. Director at Kiniksa Pharmaceuticals International, plc (KNSA) and 1 other issuer. 11 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in LONDON.
Companies McCain Tracey L has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Director
- Blueprint Medicines Corp (BPMC): Officer, EVP AND CHIEF LEGAL OFFICER
McCain Tracey L
CIK: 0001683600
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
12.2K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Units
2K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.8K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
DispositionDirect51.1K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
AwardDirect21.4K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
Tender OfferDirect37.1K shares- - Jun 5, 2025KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect3.2K shares- - Jun 3, 2025KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Units
2.8K shares- - Jun 3, 2025KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
16.8K shares- - Mar 5, 2025BPMC
Blueprint Medicines Corp
SaleDirect5.3K shares at avg. $88.80$467K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 |  KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 12,158 | - | - | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Units | 2,026 | - | - | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,799 | - | $0 | Direct |
| Jul 17, 2025 |  BPMC Blueprint Medicines Corp | Disposition | 51,103 | - | - | Direct |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | Award | 21,353 | - | - | Direct |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | Tender Offer | 37,092 | - | - | Direct |
| Jun 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 3,173 | - | - | Direct |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Units | 2,799 | - | - | Direct |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 16,798 | - | - | Direct |
| Mar 5, 2025 | BPMC Blueprint Medicines Corp | Sale | 5,262 | $88.80 | $467,266 | Direct |
1-10 of 11 transactions